ERDERA has launched its Clinical Trial Call (ECTC) to support multinational, GCP‑compliant early‑phase interventional clinical trials in rare diseases.

https://erdera.org/call/ctc2026/ ERDERA (the European Rare Diseases Research Alliance) has launched a Clinical Trial Call to support multinational, GCP-compliant Phase I, Phase I/II and Phase II interventional trials in rare diseases. Funding aims to generate robust, regulatory-relevant clinical evidence, with priority given to paediatric and rapidly progressive rare diseases, and those with no approved treatment options. Applications are open to research institutes, clinical centres, NGOs, patient advocacy organisations and SMEs. The deadline is 10 September.